These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Exclusion of ferrochelatase gene mutations in patients with seasonal palmoplantar keratoderma. Schimmel RJ; Van Tuyll Van Serooskerke AM; Bladergroen RS; Van Steensel AM; van Geel M; Pasmans SG; Frank J Cell Mol Biol (Noisy-le-grand); 2009 Jul; 55(2):111-7. PubMed ID: 19656459 [TBL] [Abstract][Full Text] [Related]
8. Late presentation of erythropoietic protoporphyria: case report and genetic analysis of family members. Berroeta L; Man I; Goudie DR; Whatley SD; Elder GH; Ibbotson SH Br J Dermatol; 2007 Nov; 157(5):1030-1. PubMed ID: 17711525 [TBL] [Abstract][Full Text] [Related]
9. A novel splicing mutation and haplotype analysis of the FECH gene in a Chinese family with erythropoietic protoporphyria. Ma J; Xiao S; An J; Wang X; Xu Q; Dong Y; Feng Y; Wang J J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):726-9. PubMed ID: 19888946 [TBL] [Abstract][Full Text] [Related]
10. Biochemical abnormality in erythropoietic protoporphyria: cause and consequences. Bloomer JR; Wang Y; Singhal A; Risheg H J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S36-40. PubMed ID: 16819399 [TBL] [Abstract][Full Text] [Related]
11. Identification of a ferrochelatase mutation in a Chinese family with erythropoietic protoporphyria. Kong XF; Ye J; Gao DY; Gong QM; Zhang DH; Lu ZM; Lu YM; Zhang XX J Hepatol; 2008 Feb; 48(2):375-9. PubMed ID: 18160121 [TBL] [Abstract][Full Text] [Related]
12. Clinical, biochemical, and genetic study of 11 patients with erythropoietic protoporphyria including one with homozygous disease. Herrero C; To-Figueras J; Badenas C; Méndez M; Serrano P; Enríquez-Salamanca R; Lecha M Arch Dermatol; 2007 Sep; 143(9):1125-9. PubMed ID: 17875872 [TBL] [Abstract][Full Text] [Related]
13. Exonic deletions as a cause of erythropoietic protoporphyria. Wood LH; Whatley SD; McKenna K; Badminton MN Ann Clin Biochem; 2006 May; 43(Pt 3):229-32. PubMed ID: 16704762 [TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of erythropoietic protoporphyria in South Africa. Parker M; Corrigall AV; Hift RJ; Meissner PN Br J Dermatol; 2008 Jul; 159(1):182-91. PubMed ID: 18460026 [TBL] [Abstract][Full Text] [Related]
15. Erythropoietic protoporphyria a clinical and molecular study from Lebanon: Ferrochelatase a potential tumor suppressor gene in colon cancer. Kadara H; Nemer G; Safi R; Rebeiz N; Daou L; Delbani D; Btadini W; Abbas O; Tofaili M; Bitar F; Kibbi AG; Shimomura Y; Kurban M Clin Genet; 2017 Nov; 92(5):495-502. PubMed ID: 28075030 [TBL] [Abstract][Full Text] [Related]
17. A point mutation affecting an SP1 binding site in the promoter of the ferrochelatase gene impairs gene transcription and causes erythropoietic protoporphyria. Di Pierro E; Cappellini MD; Mazzucchelli R; Moriondo V; Mologni D; Zanone Poma B; Riva A Exp Hematol; 2005 May; 33(5):584-91. PubMed ID: 15850836 [TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of mutations in the ferrochelatase gene in Italian patients with erythropoietic protoporphyria. Aurizi C; Schneider-Yin X; Sorge F; Macrì A; Minder EI; Biolcati G Mol Genet Metab; 2007 Apr; 90(4):402-7. PubMed ID: 17196862 [TBL] [Abstract][Full Text] [Related]
19. A novel large deletion and three polymorphisms in the FECH gene associated with erythropoietic protoporphyria. Li C; Di Pierro E; Brancaleoni V; Cappellini MD; Steensma DP Clin Chem Lab Med; 2009; 47(1):44-6. PubMed ID: 19055472 [TBL] [Abstract][Full Text] [Related]
20. The penetrance of dominant erythropoietic protoporphyria is modulated by expression of wildtype FECH. Gouya L; Puy H; Robreau AM; Bourgeois M; Lamoril J; Da Silva V; Grandchamp B; Deybach JC Nat Genet; 2002 Jan; 30(1):27-8. PubMed ID: 11753383 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]